### China channel feed #### [WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military list](https://endpoints.news/wuxi-apptec-sues-pentagon-in-challenge-over-inclusion-on-chinese-military-list/ "WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military list") 3 days ago #### [Sciwind has two Western partners for its obesity drug, but is open to more](https://endpoints.news/sciwind-has-two-western-partners-for-its-obesity-drug-but-is-open-to-more/ "Sciwind has two Western partners for its obesity drug, but is open to more") 3 days ago #### [WuXi AppTec added to Pentagon's list of companies linked to Chinese military](https://endpoints.news/wuxi-apptec-added-to-pentagon-list-of-companies-linked-to-chinese-military/ "WuXi AppTec added to Pentagon's list of companies linked to Chinese military") 6 days ago #### [In Washington, biotech's China hawks are winning the conversation](https://endpoints.news/in-washington-biotechs-china-hawks-are-winning-the-conversation/ "In Washington, biotech's China hawks are winning the conversation") Last week #### [Travere pays Everest $112M upfront to grow rare kidney disease pipeline](https://endpoints.news/travere-pays-everest-112m-upfront-to-grow-rare-kidney-disease-pipeline/ "Travere pays Everest $112M upfront to grow rare kidney disease pipeline") Last week #### [Exclusive: Bipartisan group of lawmakers unveil new bill to restrict China biotech](https://endpoints.news/citing-dangerous-deals-lawmakers-propose-china-restrictions/ "Exclusive: Bipartisan group of lawmakers unveil new bill to restrict China biotech") Last week #### [After being ditched by Candid, Rallybio finds Avenzo to take its Nasdaq listing](https://endpoints.news/after-being-ditched-by-candid-rallybio-finds-avenzo-to-take-its-nasdaq-listing/ "After being ditched by Candid, Rallybio finds Avenzo to take its Nasdaq listing") 2 weeks ago #### [Post-Hoc Live: Jeremy Levin sounds the alarm on biotech](https://endpoints.news/post-hoc-live-jeremy-levin-on-biotechs-existential-moment/ "Post-Hoc Live: Jeremy Levin sounds the alarm on biotech") 3 weeks ago #### [GOP chairman of China panel seeks biotech clampdown, calls out BMS deal](https://endpoints.news/gop-lawmaker-asks-trump-administration-to-curb-china-biotech-deals/ "GOP chairman of China panel seeks biotech clampdown, calls out BMS deal") 4 weeks ago #### [China’s drugmakers to take the stage at ASCO](https://endpoints.news/chinas-drugmakers-to-take-the-stage-at-asco26/ "China’s drugmakers to take the stage at ASCO") 4 weeks ago #### [Post-Hoc: The next big pharma company will come from China](https://endpoints.news/the-next-big-pharma-company-will-come-from-china/ "Post-Hoc: The next big pharma company will come from China") 4 weeks ago #### [Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B](https://endpoints.news/bristol-myers-joins-hengrui-party-in-13-asset-deal-worth-up-to-15-2b/ "Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B") Last month #### [GSK goes to China for $1B siRNA deal in Arrowhead's obesity lane](https://endpoints.news/gsk-goes-to-china-for-1b-sirna-deal-in-arrowheads-obesity-lane/ "GSK goes to China for $1B siRNA deal in Arrowhead's obesity lane") Last month #### [Biotech has a new company model: A small team, a big check and a few Chinese assets](https://endpoints.news/biotech-has-a-new-startup-model-small-team-big-check-and-chinese-assets/ "Biotech has a new company model: A small team, a big check and a few Chinese assets") Last month #### [Windward Bio gets $165M to take China-derived drug into Phase 3 asthma trial](https://endpoints.news/windward-bio-gets-165m-to-take-china-derived-drug-into-phase-3-asthma-trial/ "Windward Bio gets $165M to take China-derived drug into Phase 3 asthma trial") Last month #### [UCB bets $2B on Candid's T cell engager ambitions](https://endpoints.news/ucb-bets-2-billion-on-candids-t-cell-engager-ambitions/ "UCB bets $2B on Candid's T cell engager ambitions") Last month #### [Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China](https://endpoints.news/acelyrin-founder-shao-lee-lin-emerges-at-cue-as-it-becomes-latest-to-license-from-china/ "Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China") Last month #### [House panel calls for banning China data from FDA drug trial applications](https://endpoints.news/house-panel-calls-to-ban-china-trial-data-from-fda-drug-trial-applications/ "House panel calls for banning China data from FDA drug trial applications") Last month #### [MPM has collected three China drugs so far for its ‘best of both worlds’ strategy](https://endpoints.news/mpm-has-collected-three-china-drugs-for-its-best-of-both-worlds-strategy/ "MPM has collected three China drugs so far for its ‘best of both worlds’ strategy") Last month #### [FDA announces real-time clinical trial data effort, with AstraZeneca and Amgen as test cases](https://endpoints.news/fda-debuts-plan-to-collect-real-time-clinical-trial-data/ "FDA announces real-time clinical trial data effort, with AstraZeneca and Amgen as test cases") Last month #### [Revolution Medicines threatens to sue Erasca in showdown over closely watched RAS drugs](https://endpoints.news/revolution-medicines-threatens-to-sue-erasca-over-patent-efficacy-claims/ "Revolution Medicines threatens to sue Erasca in showdown over closely watched RAS drugs") Last month #### [RFK Jr. says China is 'eating our lunch' in biotech advances](https://endpoints.news/rfk-jr-says-china-is-eating-our-lunch-in-biotech-advances/ "RFK Jr. says China is 'eating our lunch' in biotech advances") Last month #### [The Q1 deal report: China dominates big licensing deals as M&A starts 2026 with a bang](https://endpoints.news/china-dominates-big-licensing-deals-as-ma-starts-2026-with-a-bang/ "The Q1 deal report: China dominates big licensing deals as M&A starts 2026 with a bang") 2 months ago #### [A ‘cure’ for five blood disease patients suggests Chinese genetic medicine can compete globally](https://endpoints.news/china-biotechs-crispr-therapy-suggests-us-drugmakers-will-face-competition/ "A ‘cure’ for five blood disease patients suggests Chinese genetic medicine can compete globally") 2 months ago